Lusso, Paolo
National Institute of Allergy and Infectious Diseases (NIAID),
United States
2025 Rank: 34,711
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 230 out of 75,944 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34,711 | 35,708 |
| Total Cites | 12,501 | 14,113 |
| H-index | 56 | 61 |
| Hm-index | 20 | 20 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 406 | 441 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 2,006 | 2,208 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 7,989 | 8,707 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,382 | 10,111 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.40 |
| Self-Citation Percentage |
11.42%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 225 out of 71,672 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32,561 | 33,767 |
| Total Cites | 12,053 | 13,627 |
| H-index | 56 | 60 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 392 | 427 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 1,956 | 2,154 |
| Number of Single+First+Last Authored Papers | 102 | 102 |
| Total Cites to Single+First+Last Authored Papers | 7,739 | 8,438 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,047 | 9,752 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.40 |
| Self-Citation Percentage |
11.55%
|
|
Lusso, Paolo
National Institute of Allergy and Infectious Diseases (NIAID),
United States
2023 Rank: 30,331
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 214 out of 68,279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30,331 | 31,197 |
| Total Cites | 11,735 | 13,282 |
| H-index | 55 | 60 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 381 | 416 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1,937 | 2,135 |
| Number of Single+First+Last Authored Papers | 99 | 99 |
| Total Cites to Single+First+Last Authored Papers | 7,566 | 8,253 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,776 | 9,462 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.40 |
| Self-Citation Percentage |
11.65%
|
|
Lusso, Paolo
National Institute of Allergy and Infectious Diseases (NIAID),
United States
2022 Rank: 27,724
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 200 out of 65,731 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27,724 | 28,922 |
| Total Cites | 11,317 | 12,824 |
| H-index | 54 | 59 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 374 | 409 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1,894 | 2,092 |
| Number of Single+First+Last Authored Papers | 98 | 98 |
| Total Cites to Single+First+Last Authored Papers | 7,336 | 8,009 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,448 | 9,112 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.41 |
| Self-Citation Percentage |
11.75%
|
|
Lusso, Paolo
National Institute of Allergy and Infectious Diseases (NIAID),
United States
2021 Rank: 26,869
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 196 out of 64,670 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26,869 | 27,948 |
| Total Cites | 11,003 | 12,498 |
| H-index | 54 | 58 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 363 | 398 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1,838 | 2,035 |
| Number of Single+First+Last Authored Papers | 94 | 94 |
| Total Cites to Single+First+Last Authored Papers | 7,155 | 7,814 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,213 | 8,874 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.41 |
| Self-Citation Percentage |
11.96%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 194 out of 58,416 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24,481 | 25,531 |
| Total Cites | 10,581 | 11,992 |
| H-index | 52 | 56 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 358 | 393 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1,796 | 1,997 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 6,923 | 7,559 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,874 | 8,489 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.41 |
| Self-Citation Percentage |
11.77%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.